Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ultrastructural findings of lung injury due to Vaccine-induced Immune Thrombotic Thrombo- cytopenia (VITT) following COVID-19 vaccination: a scanning electron microscopic study.
Congiu T, Fanni D, Piras M, Gerosa C, Cau F, Barcellona D, D'Aloja E, Demontis R, Chighine A, Nioi M, Coni P, Ravarino A, Cerrone G, Aimola V, Botta C, Scano A, Orrù G, Coghe F, Van Eyken P, La Nasa G, Saba L, Suri JS, Faa G, Marongiu F. Congiu T, et al. Among authors: aimola v. Eur Rev Med Pharmacol Sci. 2022 Jan;26(1):270-277. doi: 10.26355/eurrev_202201_27777. Eur Rev Med Pharmacol Sci. 2022. PMID: 35049004 Free article.
Fetal programming of COVID-19: may the barker hypothesis explain the susceptibility of a subset of young adults to develop severe disease?
Gerosa C, Faa G, Fanni D, Manchia M, Suri JS, Ravarino A, Barcellona D, Pichiri G, Coni P, Congiu T, Piras M, Cerrone G, Cau F, Ledda F, Aimola V, Coghe F, Porcu M, Cau R, Orru' G, Van Eyken P, La Nasa G, Castagnola M, Marongiu F, Saba L. Gerosa C, et al. Among authors: aimola v. Eur Rev Med Pharmacol Sci. 2021 Sep;25(18):5876-5884. doi: 10.26355/eurrev_202109_26810. Eur Rev Med Pharmacol Sci. 2021. PMID: 34604981 Free article. Review.
The role of fetal programming in human carcinogenesis - May the Barker hypothesis explain interindividual variability in susceptibility to cancer insurgence and progression?
Coghe F, Fanni D, Gerosa C, Ravarino A, Mureddu M, Cerrone G, Coni P, Pichiri G, Congiu T, Piras M, Cau F, Aimola V, Balestrieri A, Lai E, Manchia M, Scano A, Orrù G, La Nasa G, Van Eyken P, Saba L, Scartozzi M, Castagnola M, Faa G. Coghe F, et al. Among authors: aimola v. Eur Rev Med Pharmacol Sci. 2022 May;26(10):3585-3592. doi: 10.26355/eurrev_202205_28854. Eur Rev Med Pharmacol Sci. 2022. PMID: 35647840 Free article.
The broad landscape of follicular lymphoma: Part I.
Fratoni S, Zanelli M, Zizzo M, Sanguedolce F, Aimola V, Cerrone G, Ricci L, Filosa A, Martino G, Ascani S. Fratoni S, et al. Among authors: aimola v. Pathologica. 2020 Mar;112(1):1-16. doi: 10.32074/1591-951X-35-19. Epub 2020 Jan 22. Pathologica. 2020. PMID: 32031179 Free PMC article. Review.
The broad landscape of follicular lymphoma: Part II.
Fratoni S, Zanelli M, Zizzo M, Sanguedolce F, Aimola V, Cerrone G, Ricci L, Filosa A, Martino G, Fara AM, Annessi V, Soriano A, Ascani S. Fratoni S, et al. Among authors: aimola v. Pathologica. 2020 Jun;112(2):79-92. doi: 10.32074/1591-951X-6-20. Epub 2020 Mar 12. Pathologica. 2020. PMID: 32202535 Free PMC article. Review.
CD44: A New Prognostic Marker in Colorectal Cancer?
Ziranu P, Pretta A, Aimola V, Cau F, Mariani S, D'Agata AP, Codipietro C, Rizzo D, Dell'Utri V, Sanna G, Moledda G, Cadoni A, Lai E, Puzzoni M, Pusceddu V, Castagnola M, Scartozzi M, Faa G. Ziranu P, et al. Among authors: aimola v. Cancers (Basel). 2024 Apr 19;16(8):1569. doi: 10.3390/cancers16081569. Cancers (Basel). 2024. PMID: 38672650 Free PMC article. Review.
The human carotid atherosclerotic plaque: an observational review of histological scoring systems.
Gerosa C, Cerrone G, Suri JS, Aimola V, Cau F, Coni P, Piras M, Cau R, Balestrieri A, Scano A, Orrù G, Van Eyken P, La Nasa G, Coghe F, Castagnola M, Gibo Y, Fanni D, Saba L. Gerosa C, et al. Among authors: aimola v. Eur Rev Med Pharmacol Sci. 2023 Apr;27(8):3784-3792. doi: 10.26355/eurrev_202304_32179. Eur Rev Med Pharmacol Sci. 2023. PMID: 37140327 Free article. Review.
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors.
Ziranu P, Pretta A, Pozzari M, Maccioni A, Badiali M, Fanni D, Lai E, Donisi C, Persano M, Gerosa C, Puzzoni M, Bardanzellu F, Ambu R, Pusceddu V, Dubois M, Cerrone G, Migliari M, Murgia S, Spanu D, Pretta G, Aimola V, Balconi F, Murru S, Faa G, Scartozzi M. Ziranu P, et al. Among authors: aimola v. Sci Rep. 2023 Mar 16;13(1):4397. doi: 10.1038/s41598-023-31538-3. Sci Rep. 2023. PMID: 36928082 Free PMC article.
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression.
Ziranu P, Aimola V, Pretta A, Dubois M, Murru R, Liscia N, Cau F, Persano M, Deias G, Palmas E, Loi F, Migliari M, Pusceddu V, Puzzoni M, Lai E, Cascinu S, Faa G, Scartozzi M. Ziranu P, et al. Among authors: aimola v. Cancers (Basel). 2023 Feb 14;15(4):1212. doi: 10.3390/cancers15041212. Cancers (Basel). 2023. PMID: 36831554 Free PMC article.